Influenza Vaccines Clinical Trial
Official title:
Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
The purpose of this study was to determine whether messages about 1. relative risk of vaccination vs. other activities and 2. strength of doctor's recommendation influenced parental intention to get own child vaccinated against human papillomavirus (HPV) or Influenza.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246100 -
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado
|
N/A | |
Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
Completed |
NCT02761551 -
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates
|
N/A | |
Recruiting |
NCT05298800 -
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
|
Phase 4 | |
Completed |
NCT03735147 -
Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children
|
Phase 4 | |
Completed |
NCT02831608 -
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis
|
Phase 4 | |
Completed |
NCT02560909 -
Adjuvanted Influenza Vaccine in Stem Cell Transplant
|
Phase 4 | |
Withdrawn |
NCT01623232 -
MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly
|
Phase 1/Phase 2 | |
Completed |
NCT00961337 -
Evaluation of a School-based Influenza Vaccination Program
|
Phase 4 | |
Completed |
NCT00402805 -
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
|
Phase 4 | |
Completed |
NCT00222638 -
Influenza Vaccination and Oral Anticoagulant Therapy
|
Phase 4 | |
Active, not recruiting |
NCT03734237 -
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
|
Phase 4 | |
Completed |
NCT01013675 -
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly
|
Phase 2 | |
Completed |
NCT00306995 -
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
|
Phase 2 | |
Completed |
NCT01310413 -
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
|
Phase 3 | |
Completed |
NCT00449670 -
Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults
|
Phase 3 | |
Completed |
NCT01788228 -
Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
|
Phase 3 | |
Completed |
NCT00296270 -
Memory for Flu Facts and Myths and Effects on Vaccine Intentions
|
N/A | |
Recruiting |
NCT05521763 -
Influenza Vaccine Uptake Among Healthcare Workers
|
N/A | |
Completed |
NCT00718120 -
Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years
|
Phase 3 |